KYTX
Kyverna Therapeutics
$5.89
+$0.26 (+4.62%)Oct 28, 2026
Key metrics
The numbers that frame KYTX today
- Market cap
- $364.26M
- ROIC
- -84.8%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $5.16
- 52wk High
- $13.67
Growth
Revenue and earnings trend for KYTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KYTX
Is Kyverna Therapeutics a good buy?
No. Kyverna Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Kyverna Therapeutics is selling at a very high price.
What is the market capitalization of KYTX?
Kyverna Therapeutics's market capitalization is $364.26M.
What is the 52-week high for KYTX stock?
The 52-week high for Kyverna Therapeutics is $13.67. The current close of $5.89 is 56.9% below that high.
What is the 52-week low for KYTX stock?
The 52-week low for Kyverna Therapeutics is $5.16. The current close of $5.89 is 14.1% above that low.
Does KYTX stock pay dividends?
Kyverna Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KYTX?
Kyverna Therapeutics's Debt / Equity ratio is 0.2.